Qi Diagnostics Founder, Grover Cheung, Shares Innovation Ecosystem Insights at HKMA Global Innovation Summit
(21 November 2025)
Qi Diagnostics Limited is pleased to announce that Grover Cheung, Founder of Qi Diagnostics, served as a panelist speaker at the HKMA Innovation Summit held on November 12, 2025. As a previous winner of the 2024/25 Best Rising Star in the HKMA/HKT Global Innovation Award 2025, Mr. Cheung was invited to share experiences and insights during the panel discussion titled “Innovation as a Driver for Economic Growth: Fostering Collaboration Within the Innovation Ecosystem”.
The panel brought together distinguished leaders from award-winning innovators, academia, and strategic enterprises, including:
- Grover Cheung, Founder, Qi Diagnostics Limited (Best Rising Star Award 2024/25)
- Prof. Michael Tse, Associate Vice-President (Innovation), Director of CityU Academy of Innovation, City University of Hong Kong
- Ms. Sabrina Song, Strategic Project Manager, Vobile Group
- Prof. Martin Zhu, Co-founder of i2Cool (Innovation Champion of the Year – SME 2024/25)
The discussion was moderated by Ir Sunny Lee BBS JP, Chairman of the Hong Kong Applied Science and Technology Research Institute (ASTRI).
Drawing from Qi Diagnostics’ journey as an award-winning healthtech innovator, Mr. Cheung shared two key insights during the panel discussion:
- Innovation Gains Insights from Local to International Cooperation
Mr. Cheung emphasized that innovation in business benefits significantly from building bridges between local ecosystems and international partnerships. He shared Qi Diagnostics’ experience of developing breakthrough diagnostic technologies in Hong Kong while simultaneously expanding collaborations globally. This dual approach—staying rooted in local innovation ecosystems while reaching out internationally—provides valuable insights that accelerate innovation and open new market opportunities.
- Co-sharing Creates Greater Synergy in Product Development and Research
Highlighting the power of collaborative innovation, Mr. Cheung discussed how co-sharing and collaboration in product development and research create greater synergy across the innovation ecosystem. When organizations share knowledge, resources, and expertise, they enable faster development cycles, reduce redundant efforts, and create more impactful solutions. This collaborative approach has been instrumental in Qi Diagnostics’ success in bringing innovations like the Lung Cancer Breathalyzer (with over 90% accuracy) and FDA Certified KetoAir ketone breathalyzer to market.
These insights reflect Qi Diagnostics’ commitment to building a collaborative innovation ecosystem where knowledge flows freely between startups, established corporations, academic institutions, and policymakers—driving economic growth through shared innovation.
The event was attended by senior government officials, including Ir Tony Wong JP, Commissioner for Digital Policy of the HKSAR Government, alongside leading executives from major corporations and innovation institutions.
About Qi Diagnostics Limited
Qi Diagnostics is an innovative healthcare technology company dedicated to advancing diagnostic solutions. As the 2024/25 Best Rising Star Award winner at the HKMA/HKT Global Innovation Awards, Qi Diagnostics leads the way in healthcare innovation with its non-invasive diagnostic technologies, including the Lung Cancer Breathalyzer with high accuracy and the FDA Certified KetoAir ketone breathalyzer. The company continues to expand partnerships and collaborations to bring breakthrough solutions to markets worldwide.
For more information about Qi Diagnostics and its groundbreaking innovations, please visit http://www.qidiagnostics.com.